Anthony Nelson, PA
Physician Assistant · Glendale, AZNPI 1053696344
Payments from drug & device makers
Across 219 payments — averaging $23.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$1K
- Novo Nordisk$272
- Medtronic$266
- Pfizer$254
- Abbott$225
- plus $1K from 28 others
What the payments were for
- Food & beverage$5,247100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 104 | $1,492 |
| AstraZeneca | 22 | $1,369 |
| Novo Nordisk | 13 | $272 |
| Medtronic | 4 | $266 |
| Pfizer | 13 | $254 |
| Abbott | 10 | $225 |
| Biohaven Pharmaceuticals, Inc. | 2 | $217 |
| Boehringer Ingelheim | 8 | $171 |
| Boston Scientific | 3 | $152 |
| Amgen | 4 | $77 |
| Merck | 4 | $73 |
| Philips North America LLC | 1 | $61 |
| GSK | 3 | $57 |
| Nevro Corp. | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $48 |
| Cvrx, Inc. | 1 | $43 |
| Exact Sciences | 2 | $38 |
| Dexcom, Inc. | 2 | $37 |
| Novartis | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| IBSA Pharma Inc. | 1 | $25 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Corcept Therapeutics | 1 | $21 |
| Acerus Pharmaceuticals Corporation | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Bayer | 1 | $16 |
| Abiomed | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Ascensia Diabetes Care US Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,247 in reported general payments places this provider in the 90th percentile of 2,888 physician assistant providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 80 | $88,509 |
| OzempicSemaglutide | 64 | $81,184 |
| EliquisApixaban | 52 | $53,395 |
| FarxigaDapagliflozin Propanediol | 42 | $49,880 |
| RybelsusSemaglutide | 21 | $49,820 |
| Xigduo XrDapaglifloz Propaned/Metformin | 29 | $45,108 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $20,887 |
| JanuviaSitagliptin Phosphate | 12 | $19,220 |
| XareltoRivaroxaban | 20 | $18,904 |
| LinzessLinaclotide | 20 | $16,812 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $15,956 |
| MounjaroTirzepatide | 15 | $15,251 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $14,616 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 12 | $9,441 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $5,267 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $272 | $131,00585 claims |
| Boehringer IngelheimJardiance | $171 | $88,50980 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,369 | $71,10474 claims |
| PfizerEliquis | $254 | $53,39552 claims |
| MerckJanuvia, Janumet Xr | $73 | $28,66224 claims |
| AbbVieLinzess, Synthroid | $1,492 | $18,28239 claims |
| Lilly USA, LLCMounjaro | $13 | $15,25115 claims |
| GSKTrelegy Ellipta | $57 | $14,61618 claims |
| Arbor Pharmaceuticals, Inc.Edarbi | $12 | $3,12512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Glendale
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Kayla BrattonGlendale$39K
- Dijana MusicGlendale$14K
- Christopher HansenGlendale$13K
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Alyssa BoschenPhoenix$86K
- Christopher BeroScottsdale$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.